Cytotoxic T lymphocytes as immune-therapy in haematological practice

British Journal of Haematology

Volumn 143, Issue 2, 2008, Pages 169-179

  Leen, Ann M ^a,b   Heslop, Helen E ^b  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Immunotherapy; Stem cell transplantation; T cells; Viruses

Indexed keywords

ANTIVIRUS AGENT; CORTICOSTEROID; CYTOKINE; GAMMA INTERFERON; RITUXIMAB; VIRUS ANTIGEN;

ADENOVIRUS; ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ASSAY; CYTOKINE RELEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DRUG DOSE REDUCTION; EPSTEIN BARR VIRUS; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; LYMPHOPROLIFERATIVE DISEASE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TREATMENT OUTCOME; VIRUS INFECTION;

ADOPTIVE TRANSFER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOCYTE DEPLETION; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION IMMUNOLOGY; VIRUS DISEASES;

EID: 52649179836     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07316.x     Document Type: Review

References (81)

1. Amrolia, P.J., Muccioli-Casadei, G., Yvon, E., Huls, H., Sili, U., Wieder, E.D., Bollard, C., Michalek, J., Ghetie, V., Heslop, H.E., Molldrem, J.J., Rooney, C.M., Schlinder, J., Vitetta, E. Brenner, M.K. (2003) Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses. Blood, 102, 2292 2299.
2. Amrolia, P.J., Muccioli-Casadei, G., Huls, H., Adams, S., Durett, A., Gee, A., Yvon, E., Weiss, H., Cobbold, M., Gaspar, H.B., Rooney, C., Kuehnle, I., Ghetie, V., Schindler, J., Krance, R., Heslop, H.E., Veys, P., Vitetta, E. Brenner, M.K. (2006) Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation. Blood, 108, 1797 1808.
3. Andre-Schmutz, I., Le, D.F., Hacein-Bey-Abina, S., Vitetta, E., Schindler, J., Chedeville, G., Vilmer, E., Fischer, A. Cavazzana-Calvo, M. (2002) Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study. Lancet, 360, 130 137.
4. Baecher-Allan, C., Brown, J.A., Freeman, G.J. Hafler, D.A. (2001) CD4+ CD25high regulatory cells in human peripheral blood. Journal of Immunology, 167, 1245 1253.
5. Blazar, B.R., Taylor, P.A., Noelle, R.J. Vallera, D.A. (1998) CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses. The Journal of Clinical Investigation, 102, 473 482.
6. Boeckh, M., Nichols, W.G., Papanicolaou, G., Rubin, R., Wingard, J.R. Zaia, J. (2003) Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biology of Blood and Marrow Transplantation, 9, 543 558.
7. Boeckh, M., Erard, V., Zerr, D. Englund, J. (2005) Emerging viral infections after hematopoietic cell transplantation. Pediatric Transplantation, 9 (Suppl. 7 48 54.
8. Bollard, C.M., Gottschalk, S., Huls, M.H., Molldrem, J., Przepiorka, D., Rooney, C.M. Heslop, H.E. (2006) In vivo expansion of LMP1- and LMP2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation. Leukemia & Lymphoma, 47, 837 842.
9. Co, M.D., Orphin, L., Cruz, J., Pazoles, P., Rothman, A.L., Ennis, F.A. Terajima, M. (2008) Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine. Vaccine, 26, 1990 1998.
10. Cobbold, M., Khan, N., Pourgheysari, B., Tauro, S., McDonald, D., Osman, H., Assenmacher, M., Billingham, L., Steward, C., Crawley, C., Olavarria, E., Goldman, J., Chakraverty, R., Mahendra, P., Craddock, C. Moss, P.A. (2005) Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. The Journal of Experimental Medicine, 202, 379 386.
11. Comoli, P., Ginevri, F., Maccario, R., Frasson, C., Valente, U., Basso, S., Labirio, M., Huang, G.C., Verrina, E., Baldanti, F., Perfumo, F. Locatelli, F. (2006) Successful in vitro priming of EBV-specific CD8+ T cells endowed with strong cytotoxic function from T cells of EBV-seronegative children. American Journal of Transplantation, 6, 2169 2176.
12. Comoli, P., Basso, S., Zecca, M., Pagliara, D., Baldanti, F., Bernardo, M.E., Barberi, W., Moretta, A., Labirio, M., Paulli, M., Furione, M., Maccario, R. Locatelli, F. (2007) Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation. American Journal of Transplantation, 7, 1648 1655.
13. Cwynarski, K., Ainsworth, J., Cobbold, M., Wagner, S., Mahendra, P., Apperley, J., Goldman, J., Craddock, C. Moss, P.A. (2001) Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood, 97, 1232 1240.
14. Egli, A., Binggeli, S., Bodaghi, S., Dumoulin, A., Funk, G.A., Khanna, N., Leuenberger, D., Gosert, R. Hirsch, H.H. (2007) Cytomegalovirus and polyomavirus BK posttransplant. Nephrology, Dialysis, Transplantation, 22 (Suppl. 8 viii72 viii82.
15. Einsele, H., Rauser, G., Grigoleit, U., Hebart, H., Sinzger, C., Riegler, S. Jahn, G. (2002a) Induction of CMV-specific T-cell lines using Ag-presenting cells pulsed with CMV protein or peptide. Cytotherapy, 4, 49 54.
16. Einsele, H., Roosnek, E., Rufer, N., Sinzger, C., Riegler, S., Loffler, J., Grigoleit, U., Moris, A., Rammensee, H.G., Kanz, L., Kleihauer, A., Frank, F., Jahn, G. Hebart, H. (2002b) Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood, 99, 3916 3922.
17. Feuchtinger, T., Lang, P., Hamprecht, K., Schumm, M., Greil, J., Jahn, G., Niethammer, D. Einsele, H. (2004) Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy. Experimental Hematology, 32, 282 289.
18. Feuchtinger, T., Lucke, J., Hamprecht, K., Richard, C., Handgretinger, R., Schumm, M., Greil, J., Bock, T., Niethammer, D. Lang, P. (2005) Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation. British Journal of Haematology, 128, 503 509.
19. Feuchtinger, T., Matthes-Martin, S., Richard, C., Lion, T., Fuhrer, M., Hamprecht, K., Handgretinger, R., Peters, C., Schuster, F.R., Beck, R., Schumm, M., Lotfi, R., Jahn, G. Lang, P. (2006) Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. British Journal of Haematology, 134, 64 76.
20. Flomenberg, P., Babbitt, J., Drobyski, W.R., Ash, R.C., Carrigan, D.R., Sedmak, G.V., McAuliffe, T., Camitta, B., Horowitz, M.M., Bunin, N. Casper, J.T. (1994) Increasing incidence of adenovirus disease in bone marrow transplant recipients. Journal of Infectious Diseases, 169, 775 781.
21. Flomenberg, P., Piaskowski, V., Truitt, R.L. Casper, J.T. (1995) Characterization of human proliferative T cell responses to adenovirus. Journal of Infectious Diseases, 171, 1090 1096.
22. Foster, A.E., Bradstock, K.F., Sili, U., Marangolo, M., Rooney, C.M. Gottlieb, D.J. (2004) A comparison of gene transfer and antigen-loaded dendritic cells for the generation of CD4+ and CD8+ cytomegalovirus-specific T cells in HLA-A2+ and HLA-A2- donors. Biology of Blood and Marrow Transplantation, 10, 761 771.
23. Fujita, Y., Leen, A.M., Sun, J., Nakazawa, Y., Yvon, E., Heslop, H.E., Brenner, M.K. Rooney, C.M. (2008) Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapy. Journal of Immunotherapy Epub ahead of print Boussiotis, V.A. (2008) CD134-allodepletion allows selective elimination of alloreactive human T cells without loss of virus-specific and leukemia-specific effectors. Biology of Blood and Marrow Transplantation, 14, 518 530.
24. Gillespie, G.M., Wills, M.R., Appay, V., O'Callaghan, C., Murphy, M., Smith, N., Sissons, P., Rowland-Jones, S., Bell, J.I. Moss, P.A. (2000) Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. Journal of Virology, 74, 8140 8150.
25. Giraud, G., Priftakis, P., Bogdanovic, G., Remberger, M., Dubrulle, M., Hau, A., Gutmark, R., Mattson, J., Svahn, B.M., Ringden, O., Winiarski, J., Ljungman, P. Dalianis, T. (2008) BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts. Bone Marrow Transplantation, 41, 737 742.
26. Gotch, F., McMichael, A., Smith, G. Moss, B. (1987) Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes. The Journal of Experimental Medicine, 165, 408 416.
27. Gottschalk, S., Ng, C.Y.C., Smith, C.A., Perez, M., Sample, C., Brenner, M.K., Heslop, H.E. Rooney, C.M. (2001) An Epstein-Barr virus deletion mutant that causes fatal lymphoproliferative disease unresponsive to virus-specific T cell therapy. Blood, 97, 835 843.
28. Gottschalk, S., Rooney, C.M. Heslop, H.E. (2005) Post-transplant lymphoproliferative disorders. Annual Review of Medicine, 56, 29 44.
29. Gustafsson, A., Levitsky, V., Zou, J.Z., Frisan, T., Dalianis, T., Ljungman, P., Ringden, O., Winiarski, J., Ernberg, I. Masucci, M.G. (2000) Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells. Blood, 95, 807 814.
30. Hamel, Y., Blake, N., Gabrielsson, S., Haigh, T., Jooss, K., Martinache, C., Caillat-Zucman, S., Rickinson, A.B., Hacein-Bey, S., Fischer, A. Cavazzana-Calvo, M. (2002) Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp65 or against adenovirus and Epstein-Barr virus EBNA3C protein: a novel approach for immunotherapy. Human Gene Therapy, 13, 855 866.
31. Haque, T., Wilkie, G.M., Taylor, C., Amlot, P.L., Murad, P., Iley, A., Dombagoda, D., Britton, K.M., Swerdlow, A.J. Crawford, D.H. (2002) Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells. Lancet, 360, 436 442.
32. Haque, T., Wilkie, G.M., Jones, M.M., Higgins, C.D., Urquhart, G., Wingate, P., Burns, D., McAulay, K., Turner, M., Bellamy, C., Amlot, P.L., Kelly, D., MacGilchrist, A., Gandhi, M.K., Swerdlow, A.J. Crawford, D.H. (2007) Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood, 110, 1123 1131.
33. Hartwig, U.F., Nonn, M., Khan, S., Meyer, R.G., Huber, C. Herr, W. (2006) Depletion of alloreactive T cells via CD69: implications on antiviral, antileukemic and immunoregulatory T lymphocytes. Bone Marrow Transplantation, 37, 297 305.
34. Heslop, H.E., Brenner, M.K. Rooney, C.M. (1994) Donor T cells to treat EBV-associated lymphoma. New England Journal of Medicine, 331, 679 680.
35. Heslop, H.E., Ng, C.Y.C., Li, C., Smith, C.A., Loftin, S.K., Krance, R.A., Brenner, M.K. Rooney, C.M. (1996) Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nature Medicine, 2, 551 555.
36. Hoffmann, P., Ermann, J., Edinger, M., Fathman, C.G. Strober, S. (2002) Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. The Journal of Experimental Medicine, 196, 389 399.
37. Hoffmann, P., Eder, R., Kunz-Schughart, L.A., Andreesen, R. Edinger, M. (2004) Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood, 104, 895 903.
38. Hromas, R., Cornetta, K., Srour, E., Blanke, C. Broun, E.R. (1994) Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood, 84, 1689 1690.
39. Imashuku, S., Goto, T., Matsumura, T., Naya, M., Yamori, M., Hojo, M., Hibi, S. Todo, S. (1997) Unsuccessful CTL transfusion in a case of post-BMT Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD). Bone Marrow Transplantation, 20, 337 340.
40. Ison, M.G. (2007) Respiratory viral infections in transplant recipients. Antiviral Therapy, 12, 627 638.
41. Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J. Enk, A.H. (2001) Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. The Journal of Experimental Medicine, 193, 1285 1294.
42. Kingsley, C.I., Karim, M., Bushell, A.R. Wood, K.J. (2002) CD25+ CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. Journal of Immunology, 168, 1080 1086.
43. Kuehnle, I., Huls, M.H., Liu, Z., Semmelmann, M., Krance, R.A., Brenner, M.K., Rooney, C.M. Heslop, H.E. (2000) CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation. Blood, 95, 1502 1505.
44. Leen, A.M. Rooney, C.M. (2005) Adenovirus as an emerging pathogen in immunocompromised patients. British Journal of Haematology, 128, 135 144.
45. Leen, A.M., Sili, U., Savoldo, B., Jewell, A.M., Piedra, P.A., Brenner, M.K. Rooney, C.M. (2004a) Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications. Blood, 103, 1011 1019.
46. Leen, A.M., Sili, U., Vanin, E.F., Jewell, A.M., Xie, W., Vignali, D., Piedra, P.A., Brenner, M.K. Rooney, C.M. (2004b) Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells. Blood, 104, 2432 2440.
47. Leen, A.M., Myers, G.D., Sili, U., Huls, M.H., Weiss, H., Leung, K.S., Carrum, G., Krance, R.A., Chang, C.C., Molldrem, J.J., Gee, A.P., Brenner, M.K., Heslop, H.E., Rooney, C.M. Bollard, C.M. (2006) Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nature Medicine, 12, 1160 1166.
48. Leen, A.M., Christin, A., Khalil, M., Weiss, H., Gee, A.P., Brenner, M.K., Heslop, H.E., Rooney, C.M. Bollard, C.M. (2008) Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy. Journal of Virology, 82, 546 554.
49. Levings, M.K., Sangregorio, R. Roncarolo, M.G. (2001) Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. The Journal of Experimental Medicine, 193, 1295 1302.
50. MacKinnon, S., Papadopoulos, E.B., Carabasi, M.H., Reich, L., Collins, N.H. O'Reilly, R.J. (1995) Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: is T cell dose important in determining biological response? Bone Marrow Transplantation, 15, 591 594.
51. Martino, R., Porras, R.P., Rabella, N., Williams, J.V., Ramila, E., Margall, N., Labeaga, R., Crowe, Jr., J.E., Coll, P. Sierra, J. (2005) Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biology of Blood and Marrow Transplantation, 11, 781 796.
52. McMichael, A.J., Gotch, F., Cullen, P., Askonas, B. Webster, R.G. (1981) The human cytotoxic T cell response to influenza A vaccination. Clinical and Experimental Immunology, 43, 276 284.
53. Micklethwaite, K., Hansen, A., Foster, A., Snape, E., Antonenas, V., Sartor, M., Shaw, P., Bradstock, K. Gottlieb, D. (2007) Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 13, 707 714.
54. Mielke, S., Nunes, R., Rezvani, K., Fellowes, V.S., Venne, A., Solomon, S.R., Fan, Y., Gostick, E., Price, D.A., Scotto, C., Read, E.J. Barrett, A.J. (2008) A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique. Blood, 111, 4392 4402.
55. Myers, G.D., Krance, R.A., Weiss, H., Kuehnle, I., Demmler, G., Heslop, H.E. Bollard, C.M. (2005) Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath). Bone Marrow Transplantation, 36, 1001 1008.
56. O'Reilly, R.J., Doubrovina, E., Trivedi, D., Hasan, A., Kollen, W. Koehne, G. (2007) Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants. Immunologic Research, 38, 237 250.
57. Papadopoulos, E.B., Ladanyi, M., Emanuel, D., MacKinnon, S., Boulad, F., Carabasi, M.H., Castro-Malaspina, H., Childs, B.H., Gillio, A.P., Small, T.N., Young, J.W., Kernan, N.A. O'Reilly, R.J. (1994) Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. The New England Journal of Medicine, 330, 1185 1191.
58. Park, K.D., Marti, L., Kurtzberg, J. Szabolcs, P. (2006) In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes. Blood, 108, 1770 1773.
59. Peck, A.J., Englund, J.A., Kuypers, J., Guthrie, K.A., Corey, L., Morrow, R., Hackman, R.C., Cent, A. Boeckh, M. (2007) Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection. Blood, 110, 1681 1688.
60. Peggs, K.S., Verfuerth, S., Pizzey, A., Khan, N., Guiver, M., Moss, P.A. MacKinnon, S. (2003) Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet, 362, 1375 1377.
61. Perruccio, K., Topini, F., Tosti, A., Carotti, A., Aloisi, T., Aversa, F., Martelli, M.F. Velardi, A. (2008) Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation. Blood Cells, Molecules & Diseases, 40, 76 83.
62. Rauser, G., Einsele, H., Sinzger, C., Wernet, D., Kuntz, G., Assenmacher, M., Campbell, J.D. Topp, M.S. (2004) Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants. Blood, 103, 3565 3572.
63. Rezvani, K., Mielke, S., Ahmadzadeh, M., Kilical, Y., Savani, B.N., Zeilah, J., Keyvanfar, K., Montero, A., Hensel, N., Kurlander, R. Barrett, A.J. (2006) High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood, 108, 1291 1297.
64. Rooney, C.M., Smith, C.A., Ng, C., Loftin, S.K., Li, C., Krance, R.A., Brenner, M.K. Heslop, H.E. (1995) Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet, 345, 9 13.
65. Rooney, C.M., Smith, C.A., Ng, C.Y., Loftin, S.K., Sixbey, J.W., Gan, Y., Srivastava, D.K., Bowman, L.C., Krance, R.A., Brenner, M.K. Heslop, H.E. (1998) Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood, 92, 1549 1555.
66. Sathe, A., Ortega, S.B., Mundy, D.I., Collins, R.H. Karandikar, N.J. (2007) In vitro methotrexate as a practical approach to selective allodepletion. Biology of Blood and Marrow Transplantation, 13, 644 654.
67. Savoldo, B., Cubbage, M.L., Durett, A.G., Goss, J., Huls, M.H., Liu, Z., Teresita, L., Gee, A.P., Ling, P.D., Brenner, M.K., Heslop, H.E. Rooney, C.M. (2002) Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals. Journal of Immunology, 168, 909 918.
68. Smith, C.A., Woodruff, L.S., Kitchingman, G.R. Rooney, C.M. (1996) Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro. Journal of Virology, 70, 6733 6740.
69. Solomon, S.R., Tran, T., Carter, C.S., Donnelly, S., Hensel, N., Schindler, J., Bahceci, E., Ghetie, V., Michalek, J., Mavroudis, D., Read, E.J., Vitetta, E.S. Barrett, A.J. (2002) Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GvHD prophylaxis in allogeneic PBSC transplantation. Cytotherapy, 4, 395 406.
70. Solomon, S.R., Mielke, S., Savani, B.N., Montero, A., Wisch, L., Childs, R., Hensel, N., Schindler, J., Ghetie, V., Leitman, S.F., Mai, T., Carter, C.S., Kurlander, R., Read, E.J., Vitetta, E.S. Barrett, A.J. (2005) Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation. Blood, 106, 1123 1129.
71. Tan, L.C., Gudgeon, N., Annels, N.E., Hansasuta, P., O'Callaghan, C.A., Rowland-Jones, S., McMichael, A.J., Rickinson, A.B. Callan, M.F. (1999) A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. Journal of Immunology, 162, 1827 1835.
72. Tang, J., Olive, M., Champagne, K., Flomenberg, N., Eisenlohr, L., Hsu, S. Flomenberg, P. (2004) Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele. Gene Therapy, 11, 1408 1415.
73. Tang, J., Olive, M., Pulmanausahakul, R., Schnell, M., Flomenberg, N., Eisenlohr, L. Flomenberg, P. (2006) Human CD8+ cytotoxic T cell responses to adenovirus capsid proteins. Virology, 350, 312 322.
74. Taylor, P.A., Noelle, R.J. Blazar, B.R. (2001) CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. The Journal of Experimental Medicine, 193, 1311 1318.
75. Vella, A., Teague, T.K., Ihle, J., Kappler, J. Marrack, P. (1997) Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4. The Journal of Experimental Medicine, 186, 325 330.
76. Vella, A.T., Dow, S., Potter, T.A., Kappler, J. Marrack, P. (1998) Cytokine-induced survival of activated T cells in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America, 95, 3810 3815.
77. Veltrop-Duits, L.A., Heemskerk, B., Sombroek, C.C., van, V.T., Gubbels, S., Toes, R.E., Melief, C.J., Franken, K.L., Havenga, M., van Tol, M.J. Schilham, M.W. (2006) Human CD4+ T cells stimulated by conserved adenovirus 5 hexon peptides recognize cells infected with different species of human adenovirus. European Journal of Immunology, 36, 2410 2423.
78. Walter, E.A., Greenberg, P.D., Gilbert, M.J., Finch, R.J., Watanabe, K.S., Thomas, E.D. Riddell, S.R. (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. The New England Journal of Medicine, 333, 1038 1044.
79. Wehler, T.C., Nonn, M., Brandt, B., Britten, C.M., Grone, M., Todorova, M., Link, I., Khan, S.A., Meyer, R.G., Huber, C., Hartwig, U.F. Herr, W. (2007) Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines. Blood, 109, 365 373.
80. Zeller, J.C., Panoskaltsis-Mortari, A., Murphy, W.J., Ruscetti, F.W., Narula, S., Roncarolo, M.G. Blazar, B.R. (1999) Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta. Journal of Immunology, 163, 3684 3691.
81. Zerr, D.M., Corey, L., Kim, H.W., Huang, M.L., Nguy, L. Boeckh, M. (2005) Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clinical Infectious Diseases, 40, 932 940.